SCHEMBL4196097

SCHEMBL4196097

O=C(NS(=O)(=O)c1cccc(Cl)c1)c1ccc(N(Cc2cccnc2)c2ccc(OC(F)F)c(OC3CCCO3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.40
PDE4B Q07343 5/20 0.40
PDE4C Q08493 5/20 0.40
PDE4D Q08499 5/20 0.40
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
NAMPT P43490 3/20 0.35
ELANE P08246 1/20 0.35
HSD11B1 P28845 3/20 0.35
KMT2A Q03164 2/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 2/20 0.34
MAPT P10636 1/20 0.34
CXCR3 P49682 1/20 0.34
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202323 0.93 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4206178 0.93 PDE4B (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4193451 0.92 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DNAMPT
SCHEMBL4196473 0.92 NAMPT (0.42) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4199909 0.91 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4193923 0.91 PDE4B (0.38) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4188752 0.90 PTGS2 (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4195407 0.89 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4197063 0.89 PDE4B (0.40) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4200638 0.88 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048255-A1 PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS SCHUMACHER RICHARD A 2009-02-19 US claimed
US-20050119225-A1 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs MEMORY PHARMACEUTICALS CORP. (US) 2005-06-02 US claimed
US-20090048255-A1 PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS SCHUMACHER RICHARD A 2009-02-19 US disclosed
US-7405230-B2 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs MEMORY PHARMACEUTICALS CORPORATION (US) 2008-07-29 US disclosed
US-20050119225-A1 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs MEMORY PHARMACEUTICALS CORP. (US) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048255-A1 PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885
US-20050119225-A1 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs PDE4A, PDE4B, PDE3A PDE4A 1/4885PDE4B 2/4885PDE4C 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.